Frederic Sampedro

Vall d'Hebron Hospital Universitari — Spain

Medicine · Health Sciences

24h-index2.2kcitations91works1.32yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Neurological disorders and treatments(32), Parkinson's Disease Mechanisms and Treatments(30), Genetic Neurodegenerative Diseases(25), Functional Brain Connectivity Studies(11), Alzheimer's disease research and treatments(10)

Publications91 total

The profiling of extracellular vesicle subtypes in Huntington’s disease brains identifies Alix as a novel marker of neuropathology
Figshare·2026Open Access
The profiling of extracellular vesicle subtypes in Huntington’s disease brains identifies Alix as a novel marker of neuropathology
Figshare·2026Open Access
Additional file 2 of The profiling of extracellular vesicle subtypes in Huntington’s disease brains identifies Alix as a novel marker of neuropathology
Figshare·2026Open Access
Additional file 2 of The profiling of extracellular vesicle subtypes in Huntington’s disease brains identifies Alix as a novel marker of neuropathology
Figshare·2026Open Access
Additional file 1 of The profiling of extracellular vesicle subtypes in Huntington’s disease brains identifies Alix as a novel marker of neuropathology
Figshare·2026Open Access
Additional file 1 of The profiling of extracellular vesicle subtypes in Huntington’s disease brains identifies Alix as a novel marker of neuropathology
Figshare·2026Open Access
A randomized clinical trial to evaluate the efficacy of cognitive rehabilitation and music therapy in mild cognitive impairment in Huntington’s disease
Journal of Neurology·2025· 5 cited
21020. BASES NEURONALES DE LA DESINTEGRACIÓN DEL LENGUAJE EN LA ENFERMEDAD DE HUNTINGTON
Neurology Perspectives·2024Open Access
Facial emotion recognition deficits are associated with hypomimia and related brain correlates in Parkinson’s disease
Journal of Neural Transmission·2024· 7 cited
Editorial: Genotype–phenotype correlations in neurodegenerative diseases: From clinical features to neuroimaging signatures
Frontiers in Neurology·2022Open Access
Cortical macro and microstructural correlates of cognitive and neuropsychiatric symptoms in Parkinson’s disease
Clinical Neurology and Neurosurgery·2022· 9 cited
The role of attentional control over interference in minor hallucinations in Parkinson’s disease
Parkinsonism & Related Disorders·2022· 6 cited
Brain metabolic changes in patients with disseminated malignant melanoma under immunotherapy
Melanoma Research·2022· 1 cited
Dissociable contribution of plasma NfL and p-tau181 to cognitive impairment in Parkinson's disease
Parkinsonism & Related Disorders·2022· 30 cited
Response to letter: “Association of elevated blood homocysteine with cognitive decline in early, untreated Parkinson's disease”
Journal of the Neurological Sciences·2022
Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders
Frontiers in Neurology·2022Open Access
Measuring the functional impact of cognitive impairment in Huntington’s disease
Journal of Neurology·2022· 6 citedOpen Access
Increased homocysteine levels correlate with cortical structural damage in Parkinson's disease
Journal of the Neurological Sciences·2022· 24 citedOpen Access
Structure and Dynamics of Large‐Scale Cognitive Networks in Huntington's Disease
Movement Disorders·2021· 18 citedOpen Access
Tipping the scales: how clinical assessment shapes the neural correlates of Parkinson’s disease mild cognitive impairment
Brain Imaging and Behavior·2021· 9 cited
page 1 of 5Next →

Frequent Co-authors

Saül Martínez‐Horta(37), Jaime Kulisevsky(36), Javier Pagonabarraga(31), Juan Marín‐Lahoz(22), Jesús Pérez‐Pérez(20), Andrea Horta‐Barba(19), Beatriz Gómez‐Ansón(17), Valle Camacho(12), Antònia Campolongo(11), Ignacio Aracil‐Bolaños(11), Berta Pascual‐Sedano(10), Helena Bejr‐Kasem(10), Daniel Alcolea(7), Diego Alfonso López-Mora(7), Alberto Lleó(7), Jordi Clarimón(6), Rafael Blesa(6), Juan Fortea(6), Ignasi Carrió(6), Jordi Riba(5)